Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease

---

Copy For Citation

COLAK Y., SENATES E., OZTURK O., DOGANAY H. L., Coskunpinar E. M., Oltulu Y. M., ...More

METABOLIC SYNDROME AND RELATED DISORDERS, vol.10, no.2, pp.103-109, 2012 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 10 Issue: 2
• Publication Date: 2012
• Doi Number: 10.1089/met.2011.0111
• Journal Name: METABOLIC SYNDROME AND RELATED DISORDERS
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.103-109
• Istanbul University Affiliated: Yes

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is one of the most common causes of chronic liver disease, worldwide. Lipoprotein-associated phospholipase A2 (Lp-PLA2) was recently characterized as a novel inflammatory biomarker that is correlated with several components constituting the metabolic syndrome.